Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical

Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical

VoM News Desk | January 18, 2024 | 12:48 PM IST | Breaking News | Follow on Google News

Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical/BS

Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical

India’s Sun Pharmaceutical Industries Ltd has revealed plans to acquire the remaining outstanding shares of Taro Pharmaceutical Industries Ltd. Valued at approximately 2,891 crore Indian Rupees, this strategic move is expected to strengthen Sun Pharma’s global position.

The acquisition, subject to regulatory approvals, is anticipated to enhance operational efficiency and contribute to long-term growth.

The deal is set to close in the first half of 2024, leading to Taro becoming a privately held company.

VoM News Desk

VoM News is an online web portal in jammu Kashmir offers regional, National & global news.